GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » Meilleure Health International Industry Group Ltd (HKSE:02327) » Definitions » Research & Development

Meilleure Health International Industry Group (HKSE:02327) Research & Development : HK$0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Meilleure Health International Industry Group Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Meilleure Health International Industry Group's Research & Development for the six months ended in Dec. 2024 was HK$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.00 Mil.


Meilleure Health International Industry Group Research & Development Historical Data

The historical data trend for Meilleure Health International Industry Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meilleure Health International Industry Group Research & Development Chart

Meilleure Health International Industry Group Annual Data
Trend Mar15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Meilleure Health International Industry Group Semi-Annual Data
Mar15 Sep15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Meilleure Health International Industry Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Meilleure Health International Industry Group  (HKSE:02327) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Meilleure Health International Industry Group Research & Development Related Terms

Thank you for viewing the detailed overview of Meilleure Health International Industry Group's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Meilleure Health International Industry Group Business Description

Traded in Other Exchanges
N/A
Address
89 Queensway, Unit 2906, Tower 1, Lippo Centre, Admiralty, Hong Kong, HKG
Meilleure Health International Industry Group Ltd is an investment holding company principally engaged in the trading of healthcare products, chemical materials, and building materials. The company's operating segment includes Healthcare related business; Trading business; Property related business; and Equity investment business. The Trading business segment includes the trading of construction materials. Geographically, it derives a majority of revenue from PRC, and also it has its presence in Hong Kong, Europe and Others.
Executives
Shunda Investment Limited 2201 Interest of corporation controlled by you
Zhongjia U-home Investment Limited 2101 Beneficial owner
Zhou Xuzhou 2201 Interest of corporation controlled by you
U-home Group International Ltd
Anhui Yuhua Enterprises Company Limited
Kambert Enterprises Limited
U-home Group Investment Limited
U-home Property (group) Limited
Yee Sheng Enterprises Company Limited
Yuhua Enterprises Company Limited
Haitong Ut Leasing Hk Limited 2106 Person having a security interest in shares
Haitong International Finance Company Limited

Meilleure Health International Industry Group Headlines

No Headlines